Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
REGEnLIFE tests light stimulation on neurodegenerative diseases
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases

Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation

15th Clinical Trials on Alzheimer’s Disease (CTAD) 2022, San Francisco
CTAD 2023

Julien Delrieu, Aroa Relano-Gines, Patrice Cristofini, Julie Bisiaux, Sara Guillemin, Guillaume Blivet, Jacques Touchon

Share this article